Clinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: an Infectious Diseases Society of America/American Society for Microbiology Consensus Review Document | Zendy

Alexander L. Greninger | Zendy; Jennifer Dien Bard | Zendy; Robert C. Colgrove | Zendy; Erin H. Graf | Zendy; Kimberly E. Hanson | Zendy; Mary K. Hayden | Zendy; Romney M. Humphries | Zendy; Christopher F. Lowe | Zendy; Melissa B. Miller | Zendy; Dylan R. Pillai | Zendy; Daniel D. Rhoads | Zendy; Joseph D. Yao | Zendy; Francesca M Lee | Zendy

Open Access

Clinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: an Infectious Diseases Society of America/American Society for Microbiology Consensus Review Document

Author(s) -

Alexander L. Greninger,

Jennifer Dien Bard,

Robert C. Colgrove,

Erin H. Graf,

Kimberly E. Hanson,

Mary K. Hayden,

Romney M. Humphries,

Christopher F. Lowe,

Melissa B. Miller,

Dylan R. Pillai,

Daniel D. Rhoads,

Joseph D. Yao,

Francesca M Lee

Publication year - 2021

Publication title -

journal of clinical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.349

H-Index - 255

eISSN - 1070-633X

pISSN - 0095-1137

DOI - 10.1128/jcm.01659-21

Subject(s) - genotyping , covid-19 , coronavirus , virology , medicine , clinical microbiology , biology , immunology , genotype , infectious disease (medical specialty) , disease , genetics , gene , microbiology and biotechnology

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged into a world of maturing pathogen genomics, with more than 2 million genomes sequenced at the time of writing. The rise of more transmissible variants of concern that impact vaccine and therapeutic effectiveness has led to widespread interest in SARS-CoV-2 evolution.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research